Mutya Harsch - 31 Mar 2023 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
Chief Legal Officer and GC
Signature
/s/ Mutya Harsch
Issuer symbol
VYNE
Transactions as of
31 Mar 2023
Net transactions value
-$1,472
Form type
4
Filing time
04 Apr 2023, 17:03:51 UTC
Previous filing
22 Mar 2023
Next filing
02 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Tax liability $1,472 -478 -2.1% $3.08 22,243 31 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.